11 September 2020: Clinical Research
A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China
Miao Yang 1ACDEG , Xiaoping Chen 2ABCF* , Yancheng Xu 1ADFG*DOI: 10.12659/MSM.926393
Med Sci Monit 2020; 26:e926393
Table 2 Laboratory results of 108 COVID-19 patients.
| Normal range | Total (n=108) | Non-severe (n=84) | Severe (n=24) | P-value | |
|---|---|---|---|---|---|
| White blood cell count (×10/L) | 3.5–9.5 | 4.2 (3.0, 5.7) | 4.2 (3.0, 5.3) | 5.0 (3.0, 7.3) | 0.124 |
| Hemoglobin (g/L) | 115–150 | 127.4 (117.4, 139.2) | 128.7 (117.7, 139.9) | 126.0 (109.3, 134.8) | 0.074 |
| Platelet count (×10/L) | 125–350 | 180.0 (140.3, 227.5) | 181.5 (142.0, 227.5) | 174.0 (121.3, 231.8) | 0.888 |
| Lymphocyte count (×10/L) | 1.1–3.2 | ||||
| Neutrophil count (×10/L) | 1.8–6.3 | 2.6 (1.8, 3.7) | 2.5 (1.6, 3.5) | 3.1 (1.8, 5.5) | 0.042 |
| Monocyte count (×10/L) | 0.1–0.6 | 0.4 (0.3, 0.5) | 0.4 (0.3, 0.5) | 0.4 (0.2, 0.6) | 0.947 |
| Alanine aminotransferase (U/L) | 9–50 | 22.0 (15.0, 34.5) | 21.0 (14.0, 28.0) | 33.0 (19.3, 52.3) | 0.021 |
| Aspartate aminotransferase (U/L) | 15–40 | 25.0 (19.0, 37.0) | 24.0 (18.0, 30.0) | 39.5 (22.3, 60.3) | 0.002 |
| Total bilirubin (mmol/L) | 5–21 | 10.1 (8.0, 13.5) | 9.7 (7.8, 12.9) | 11.0 (8.7, 17.1) | 0.121 |
| Creatinine (μmol/L) | 64–104 | 61.6 (52.3, 73.6) | 60.4 (51.5, 73.2) | 67.6 (55.4, 81.9) | 0.142 |
| C-reactive protein (mg/L) | 0–10.0 |